Clinical Trial Update: Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma

View source ↗

Summary

This clinical trial update reports ongoing recruitment for second-line regimens based on albumin-bound paclitaxel to treat locally advanced or metastatic gastri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer, Second-line Treatment | Status: RECRUITING